Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels
Anthony Dobi(University of Reunion Island), Philippe Gasque(Institut de Recherche pour le Développement)
Cited by 6
Related Papers
Methotrexate an Old Drug with New Tricks
|International Journal of Molecular Sciences|2019|446
Decay-Accelerating Factor (CD55) Is Expressed by Neurons in Response to Chronic but Not Acute Autoimmune Central Nervous System Inflammation Associated with Complement Activation
|The Journal of Immunology|2005|68
Deciphering the differential response of two human fibroblast cell lines following Chikungunya virus infection
|Virology Journal|2012|35
Major Neutrophilia Observed in Acute Phase of Human Leptospirosis Is Not Associated with Increased Expression of Granulocyte Cell Activation Markers
|PLoS ONE|2016|27
Inflammatory Mesenchymal Stem Cells Express Abundant Membrane-Bound and Soluble Forms of C-Type Lectin-like CD248
|International Journal of Molecular Sciences|2023|9